• All News
• Consumer
• Pro
• New Drugs
• Pipeline
• Clinical Trials
• FDA Alerts

Black Patients With Peripheral Artery Disease Have Worse Outcomes

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

TUESDAY, July 18, 2023 -- There are significant racial disparities in the diagnosis, treatment, and outcomes of peripheral artery disease (PAD), according to a study recently published in Advances in Therapy.

Keith C. Ferdinand, M.D., from the Tulane University School of Medicine in New Orleans, and colleagues compared rates of diagnostic testing, treatment patterns, and outcomes after diagnosis of PAD among commercially insured Black and White patients in the United States. The analysis included 669,939 patients with PAD identified from the Optum deidentified Clinformatics Data Mart Database (January 2016 to June 2021).

The researchers found that prevalence of diagnostic testing, revascularization procedures, and medication use was more common among Black patients. Additionally, Black patients were also more likely to receive medical therapy without a revascularization procedure versus White patients (adjusted odds ratio, 1.47). Incidence of major adverse limb events (MALE) and cardiovascular events (CV) were higher among Black patients with PAD than White patients (adjusted hazard ratio for composite event, 1.13). Risk for individual components of MALE and CV events were also significantly higher among Black patients with PAD, with the exception of myocardial infarction.

"Results of this real-world study suggest that Black patients with PAD have higher disease severity at the time of diagnosis and are at increased risk of experiencing adverse outcomes following diagnosis," the authors write.

Abstract/Full Text

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Posted July 2023

More news resources

• FDA Medwatch Drug Alerts
• Daily MedNews
• News for Health Professionals
• New Drug Approvals
• New Drug Applications
• Drug Shortages
• Clinical Trial Results
• Generic Drug Approvals

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.